Wound Care News and Research

RSS

Woodside Capital to assist in growth of Spectros' flagship product

Spectros announced today the retention of Woodside Capital Partners International to explore strategic options to accelerate the growth of its proprietary second-generation perfusion monitoring platform.

1 Apr 2013

AAWC translates patient education brochure on pressure ulcers into Spanish

The Association for the Advancement of Wound Care announces that its latest patient education brochure on the prevention and treatment of pressure ulcers, "Take the Pressure Off!" has been translated into Spanish.

30 Mar 2013

New research to focus on sensors for advanced wound care

An innovative research agreement will put patients first in a bid to advance technology in the treatment and management of wounds - saving valuable time and money for health organisations throughout the world and helping to deliver safe and effective care.

14 Mar 2013

Sanford Health announces new limb preservation program

Sanford Health announces a new limb preservation program, Sanford Limb Preservation Center. The center specializes in treating lower extremity wounds in patients at high risk of amputation and compromised leg and toe function, particularly those with diabetes and peripheral arterial disease.

5 Mar 2013

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

EO2 Concepts has developed an innovative dressing for difficult-to-heal wounds that is as easy to apply as a Band-Aid.

23 Feb 2013

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.

21 Feb 2013

Epic Wound Care enters beta test agreement with Ryan Network for UEEC's hemostatic gauze

United Health Products, Inc.'s www.unitedhealthproductsinc.com wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, is pleased to announce that it has entered into a beta test agreement with the distinguished Ryan Network for UEEC's hemostatic gauze. The gauze is registered and branded in the USA under the trademark HemoStyp.

15 Feb 2013

Cardinal Health announces plans to acquire AssuraMed

Cardinal Health today announced plans to acquire privately held AssuraMed, a leading provider of medical supplies to patients in the home, for $2.07 billion, or $1.94 billion, net of the present value of tax benefits.

15 Feb 2013

FDA allows Scioderm’s SD-101 IND application for Epidermolysis Bullosa to proceed

Scioderm announced that the US Food and Drug Administration (FDA) has reviewed and allowed the investigational new drug (IND) application for SD-101 to proceed. SD-101 is a topical treatment being developed for the treatment of Epidermolysis Bullosa (EB).

14 Feb 2013

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.

10 Feb 2013

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.

7 Feb 2013

Enterprise Ireland welcomes Irish Minister to its pavilion at Arab Health 2013

Enterprise Ireland Dubai, the regional arm of the Irish government organisation responsible for the development and growth of Irish enterprises in world markets, welcomed Minister Costello TD, Irish Minister of State for Trade and Development to its pavilion at this year's Arab Health exhibition.

30 Jan 2013

Project shows simple steps reduce hospital infections

Seven health care institutions participated in a quality-improvement project advanced by the Joint Commission and the American College of Surgeons to reduce colorectal surgical-site infection rates. During a two and a half year period, those facilities saved more than $3.7 million by avoiding 135 infections.

30 Nov 2012

Diabetic foot complication risk highlighted in men

Men should be considered for aggressive treatment for foot complications associated with diabetes, such as ulceration and amputation, say researchers.

8 Nov 2012

Hurricane Sandy’s impact on home care: an interview with Joanne Cunningham

Home care agencies, like all health providers, have only a matter of days to prepare for a specific weather event like Hurricane Sandy. However, disaster preparedness planning is a core function of home care service providers.

2 Nov 2012

MiMedx third quarter revenue increases 270% to $8.0 million

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2012.

30 Oct 2012

Derma Sciences to initiate DSC127 Phase 3 program in diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported that based on a meeting held last week with the U.S. Food and Drug Administration (FDA), the Company plans to begin its Phase 3 program in December 2012 in support of a New Drug Application (NDA) for DSC127 for treatment of diabetic foot ulcers.

23 Oct 2012

Medication management, wound care part of new normal for caregivers

Today, AARP Public Policy Institute (PPI) and the United Hospital Fund (UHF) released a new report that finds 46 percent of family caregivers perform medical and nursing tasks for care recipients with multiple chronic physical and cognitive conditions.

1 Oct 2012

Celleration introduces new MIST 360 Applicator

Celleration, Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announces the launch of its new MIST 360 Applicator.

25 Sep 2012